We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The House and Senate conferees met Wednesday to mark up the Comprehensive Addiction and Recovery Act, making a few changes but leaving intact two critical elements related to opioid approval and FDA oversight. Read More
GW Pharmaceuticals’ cannabis-based Lennox-Gastaut syndrome treatment Epidiolex shined in a Phase 3 trial, reaching its primary endpoint of a significant reduction in the monthly frequency of atonic seizures compared to a placebo over a 14-week treatment period. Read More
House Republicans have rolled out a broad proposal to replace the Affordable Care Act that includes several measures to streamline drug development. Read More